Henry Ford Health System, Division of Pulmonary and Critical Care Medicine, Detroit, Michigan, USA.
COPD. 2012 Feb;9(1):22-8. doi: 10.3109/15412555.2012.630701.
On spirometry the FEV(1)/FEV(6) ratio has been advocated as a surrogate for the FEV(1)/FVC. The significance of isolated reductions in either the FEV(1)/FEV(6) or FEV(1)/FVC is not known.
First-time adult spirograms (n = 22,837), with concomitant lung volumes (n = 12,040), diffusion (n = 14,154), and inspiratory capacity (n = 12,480) were studied. Four groups were compared. 1) Only FEV(1)/FEV(6) reduced (n = 302). 2) Only FEV(1)/FVC reduced (n = 1158). 3) Both ratios reduced (n = 6593). 4) Both ratios normal (n = 14,784).
In patients with obstructed spirometry (either a reduced FEV(1)/FVC and/or FEV(1)/FEV(6)), 3.8% only had a reduced FEV(1)/FEV(6), while 14.4% only had a reduced FEV(1)/FVC. The mean FEV(1) was lower when both ratios were reduced. The group with only a reduced FEV(1)/FEV(6), compared to only the FEV(1)/FVC reduced, had a lower FEV(1), FVC, BMI, Expiratory Time, and IC (p values < 0.0001). DL(CO) was also lower (p = 0.005), and the FEV(1)/FVC and RV/TLC were higher (p values < 0.0001). When the patients with only a reduced FEV(1)/FEV(6) had a subsequent spirogram, 60% had a reduced FEV(1)/FVC when their mean expiratory times were 3.5 seconds longer. Ninety percent of this group had strong clinical evidence of airways obstruction.
The FEV(1)/FEV(6) is not as sensitive as the FEV(1)/FVC for diagnosing airways obstruction, but in the presence of a normal FEV(1)/FVC, subjects have greater physiologic abnormalities than when only the FEV(1)/FVC is reduced. The FEV(1)/FEV(6) ratio should not replace the FEV(1)/FVC as the standard for airways obstruction, but there is benefit including this measurement to identify individuals with greater air trapping and diffusion abnormalities.
在肺量测定中,FEV(1)/FEV(6)比值被认为是 FEV(1)/FVC 的替代指标。但是,单独降低 FEV(1)/FEV(6)或 FEV(1)/FVC 的意义尚不清楚。
对首次进行成人肺量测定(n=22837),同时进行肺容积(n=12040)、弥散功能(n=14154)和吸气量(n=12480)检测的患者进行研究。比较了以下 4 组患者:1)仅 FEV(1)/FEV(6)降低(n=302);2)仅 FEV(1)/FVC 降低(n=1158);3)两个比值均降低(n=6593);4)两个比值均正常(n=14784)。
在肺量测定结果为阻塞性通气功能障碍(FEV(1)/FVC 和/或 FEV(1)/FEV(6)降低)的患者中,仅有 3.8%的患者仅存在 FEV(1)/FEV(6)降低,而 14.4%的患者仅存在 FEV(1)/FVC 降低。与仅 FEV(1)/FVC 降低的患者相比,两个比值均降低的患者的 FEV(1)水平更低。与仅 FEV(1)/FEV(6)降低的患者相比,仅 FEV(1)/FVC 降低的患者的 FEV(1)、FVC、BMI、呼气时间和 IC 均更低(p 值均<0.0001)。DL(CO)也更低(p=0.005),而 FEV(1)/FVC 和 RV/TLC 则更高(p 值均<0.0001)。当仅存在 FEV(1)/FEV(6)降低的患者进行后续肺量测定时,当平均呼气时间延长 3.5 秒时,60%的患者会出现 FEV(1)/FVC 降低。该组患者中有 90%具有明显的气道阻塞临床证据。
FEV(1)/FEV(6)对于诊断气道阻塞的敏感性不如 FEV(1)/FVC,但是在 FEV(1)/FVC 正常的情况下,与仅 FEV(1)/FVC 降低的患者相比,患者存在更多的生理异常。FEV(1)/FEV(6)比值不应替代 FEV(1)/FVC 作为气道阻塞的标准,但将该指标纳入其中有助于识别存在更多空气潴留和弥散功能异常的患者。